Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC

• Catherine Daniel, MD, PhD,
• Celine Callens, PharmD, PhD,
• Samia Melaabi, MD,
• Ivan Bieche, PharmD, PhD,
• Nicolas Girard, MD, PhD

Affiliations

Catherine Daniel, MD, PhD

Oncology Department, Institut Curie, Paris, France; Corresponding author. Address for correspondence: Catherine Daniel, MD, PhD, Oncology Department, Institut Curie, 26 rue d’Ulm, 75005 Paris, France.

Celine Callens, PharmD, PhD

Genetics Department Institut Curie, Paris, France

Samia Melaabi, MD

Genetics Department Institut Curie, Paris, France

Ivan Bieche, PharmD, PhD

Genetics Department Institut Curie, Paris, France

Nicolas Girard, MD, PhD

Oncology Department, Institut Curie, Paris, France